Indian Pharmacopoeia 2026 debuts with 121 new monographs targeting TB, diabetes, and cancer
Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
